Cipla Limited
PPFAS Mutual Fund trimmed its stake in Cipla from 1.87% to 1.86%, selling 68,127 shares.
A leading pharmaceutical manufacturer, Cipla develops and markets branded and generic formulations alongside active pharmaceutical ingredients across multiple therapeutic areas. Established in 1935, the company operates manufacturing facilities across India and internationally, serving both domestic and global markets. Cipla's distinctive strength lies in its integrated business model combining formulation development with API production, enabling cost-efficient drug manufacturing, distribution, and accessibility to patients worldwide.
Founded by Parag Parikh Financial Advisory Services, best known for the Parag Parikh Flexi Cap Fund which invests in both Indian equities and select global large-caps including Meta, Alphabet, and Microsoft. Manages over Rs 1.2 lakh crore with a concentrated, long-duration, value-focused approach. CIO Rajeev Thakkar is one of India's most respected investors with a Munger-influenced thinking style.